Page last updated: 2024-08-24

plerixafor and Leukemia, Promyelocytic, Acute

plerixafor has been researched along with Leukemia, Promyelocytic, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campestri, R; Castro, M; Fernandez, M; Jaimovich, G; Rosales Ostriz, B; Silveyra, D1
Bridger, G; DiPersio, JF; Holt, MS; Ley, TJ; Nervi, B; Piwnica-Worms, D; Prior, JL; Ramirez, P; Rettig, MP; Ritchey, JK; Uy, GL1

Other Studies

2 other study(ies) available for plerixafor and Leukemia, Promyelocytic, Acute

ArticleYear
Plerixafor, cyclophosphamide and G-CSF and Blood cell mobilization in a patient with acute promyelocytic leukemia.
    Journal of clinical apheresis, 2017, Volume: 32, Issue:6

    Topics: Benzylamines; Blood Cells; Cyclams; Cyclophosphamide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged

2017
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.
    Blood, 2009, Jun-11, Volume: 113, Issue:24

    Topics: Animals; Anti-HIV Agents; Antimetabolites, Antineoplastic; Apoptosis; Benzylamines; Bone Marrow; Cathepsin G; Cathepsins; Colony-Forming Units Assay; Cyclams; Cytarabine; Drug Synergism; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Mice; Mice, Inbred C57BL; Protein Transport; Receptors, CXCR4; Serine Endopeptidases; Stromal Cells; Tumor Cells, Cultured

2009